Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / General / Vision / February 2005

Tip: Looking for answers? Try searching our database.

The effect of a +2.0 diopter lens on refractive status of natural eye

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
otisbrown@pa.net - 18 Feb 2005 04:11 GMT
Dear Friends,

Since RM posts "blasts" against vision scientists
like Dr. Francis Young, I hardly judge
it is worth it to respond -- since
RM referred to Dr. Francis Young and other Blah
Blah.  Apperently RM has NO RESPECT for this
gifted vision scientist.

RM > OTIS, PLEASE EXPLAIN WHY STUDIES ON HUMAN SUBJECTS SHOW NO EFFECT
ON MYOPIA PROGRESSION USING PLUS LENSES.

The Oakley-Young study demonstrated that a "high plus"
where the child actually looked THROUGH THE PLUS
had the effect of stopping the "downward" change
of refractive status for these young children.

The over-all result was that the test-group
show a rate of (approximagely) zero diopters,
where the control-group (single-vision minus)
showed a "downward" rate of -1/2 diopter per year.

This suggests that the use of the plus AT THE THRESHOLD
would stop the deveopment of nearsighedness
AT THE THRESHOLD -- if used logically and
agressively.

The practical problems (lack of motivation of the person)
are well-understood by me.  That does become
a question of how "motivated" a person can,
and must be at the threshold.

Further it is clear that the "judgment faculity" must
be a matter of THAT PERSON's scientific (and engineering)
training.

The plus simply can not "casually" be prescribed for
prevention -- and NOT as a "medical" device.

Best,

Otis
Engineer
Mike Tyner - 18 Feb 2005 05:54 GMT
> RM referred to Dr. Francis Young and other Blah
> Blah.  Apperently RM has NO RESPECT for this
> gifted vision scientist.

Too many textbooks contradict your gifted scientist.

So medical texts don't count?

Show us it works and we'll use it, I promise.

-MT
g.gatti@agora.it - 18 Feb 2005 09:23 GMT
> Too many textbooks contradict your gifted scientist.

Now the truth is in the hands of a majority?

This is your science: the dominance of the gullible mass.
otisbrown@pa.net - 18 Feb 2005 19:32 GMT
Dear Friends,

Subject:  Asking for information concerning
scientific research -- and then TOTALLY INGNORING IT.

As ususal -- Mike asks for infromation -- and then
thinks up endless excuses and "rationalizations"
to totally ignore scientific research.

The next thing Mike will do it post "blasts"
against all researches who do not do things
that HE approves of.

Talk about intellectual blindness of a
closed mind.

But, as always, you decide.

Best,

Otis
Engineer

_________________

> > RM referred to Dr. Francis Young and other Blah
> > Blah.  Apperently RM has NO RESPECT for this
[quoted text clipped - 7 lines]
>
> -MT
Mike Tyner - 19 Feb 2005 05:00 GMT
> As ususal -- Mike asks for infromation -- and then
> thinks up endless excuses and "rationalizations"
> to totally ignore scientific research.

So you DO have human results?

Show us it works, in the target population, and we'll use it. I promise.

-MT
Neil Brooks - 19 Feb 2005 05:14 GMT
So, Otis . . .

Despite my best efforts at adding you and your pet topic to my
killfile in every conceivable permutation, here you are again.

A couple quick things:

   1) I suppose the bar for "proof" should be lower for you than for
the rest of the scientific community because you want it to be?  Seems
a little narcissistic and self-serving;

   2) In the wake of recent events (Aleve, Vioxx, Celebrex, etc.) I'm
reminded that scientific hypotheses should be held to the /highest/ of
scrutiny before introduced as "safe," "accurate," "state-of-the-art,"
or "conventional wisdom."  Reach for it, Mister.  It's up there for
you to surmount.

Time and time again, you eagerly and blithely foist your theories on
unsuspecting folks who stop by S.M.V. looking for help.  The general
public must rely on the kindly doctors to alert them to your lack of
credentials, potential for harm, and untested hypotheses.

Look, Otis, I'll allow for the possibility that /all/ of the eye
doctors on this NG /could possibly be/ avaricious, self-serving
monsters who have a lock on a huge chunk of change that comes from
doing things "their" way.  They may be a member of the vast ocular
conspiracy that defends its wealth by maintaining the status quo.  All
of this /may/ be true, though I don't think so.

But you still come across as a petulant, Napoleonic idiot.

The bar for proving your theories is the same as it is for all others.
Go prove your theories (yes, the old fashioned way: proper testing,
accurate data, peer-review) and -- if there's a kernel of truth in
what you spout -- you'll be rich and you'll be right up there with
Bagolini, Heimholz, Donders, Schirmer, Robert A. Strabismus, and all
the other paragons whose names are memorialized in
ophthalmology/optometry.

Until then, you're a troll . . . who creates risk for unsuspecting,
often desperate, people seeking help.  "Engineer" in your signature
expiates some of your guilt.  It does nothing to ameliorate the risk.
Perhaps if your signature said, "I am not a doctor.  My theories are
my own and are not shared by most in the medical community.  Consult
your doctor."

Neil
RM - 19 Feb 2005 05:40 GMT
> Dear Friends,
>
> Subject:  Asking for information concerning
> scientific research -- and then TOTALLY INGNORING IT.

Foolish Otis,

Valid scientific studies have failed to show a preventative effect on myopia
progression using plus lens treatment on the human eye.  You have been
informed of this over and over again by people who hold advanced degrees in
vision science.  Why do you pretend to know better.

It is YOU who TOTALLY IGNORS our request to produce proof of your claims.

I direct you to the following two articles.   Now you tell me what data YOU
have.  Skip the anecdotal reports of pseudomyopes.  Skip the old non-blinded
studies without controls.  Skip your reminescent stories about "The Printers
Son".  I'm talking about real valid controlled scientific studies.  And
since you can't find them, then spend your energy producing them.  We would
love nothing more than to offer an effective form of treatment to our
patients.  Quit pontificating and prove it to the medical community.

But until then, all you offer is false hopes and snake-oil.

Saw et al. British Journal Ophthalm. 2002 86: 1306
Saw et al. Ophthalmology 2002 109: 415.

RM  PhD OD
Neil Brooks - 19 Feb 2005 16:20 GMT
And again, your anecdotal evidence is more credible than the National
Eye Institute's multicenter, randomized, double-masked clinical trial .
. . WHY?

Note the conclusion: "Use of PALs compared with SVLs slowed the
progression of myopia in COMET children by a small, statistically
significant amount only during the first year. The size of the
treatment effect remained similar and significant for the next 2 years.
The results provide some support for the COMET rationale-that is, a
role for defocus in progression of myopia.

The small magnitude of the effect does not warrant a change in clinical
practice."

Now, would you kindly set up a better study that controverts this one?
Or, at least, go find out whether ANY of the participants in this study
has changed his or her clinical practice in ANY way as a result.

=======================================================Correction of Myopia Evaluation Trial (COMET)

Purpose
To evaluate whether progressive addition lenses (PALs) slow the rate of
progression of juvenile-onset myopia (nearsightedness) when compared
with single vision lenses, as measured by cycloplegic autorefraction.
An additional outcome measure is axial length, as measured by A-scan
ultrasonography.
To describe the natural history of juvenile-onset myopia in a group of
children receiving conventional treatment (single vision lenses).
Background
Myopia (nearsightedness) is an important public health problem, which
entails substantial societal and personal costs. It is highly prevalent
in our society and even more frequent in Asian countries; furthermore,
its prevalence may be increasing over time. High myopia contributes to
significant loss of vision and blindness. At present, the mechanisms
involved in the etiology of myopia are unclear, and there is no way to
prevent the condition. Current methods of correction require lifelong
use of lenses or surgical treatment, which is expensive and may lead to
complications. The rationale for this trial, the Correction of Myopia
Evaluation Trial (COMET), arises from the convergence of research
involving (1) the link between accommodation and myopia in children and
(2) animal models of myopia showing the important role of the visual
environment in eye growth. A contribution of this research is that blur
is a critical component in the development of myopia. The primary aim
of COMET, to evaluate the efficacy of progressive addition lenses, a
noninvasive intervention, in slowing the progression of myopia, follows
from this line of reasoning. These lenses should provide clear visual
input over a range of viewing distances without focusing effort by the
child. The comparison of myopia progression in children treated with
PALs versus single vision lenses will allow the quantification of the
effect of PALs on myopia progression during the followup period.

Description
The COMET is a multicenter, randomized, double-masked clinical trial to
evaluate whether PALs slow the progression of juvenile-onset myopia as
compared with single vision lenses. The study is a collaborative effort
that involves a Study Chair at the New England College of Optometry;
four clinical centers at colleges of optometry in Boston, Birmingham,
Philadelphia, and Houston; and a Coordinating Center at the State
University of New York at Stony Brook.

The sample size goal, 450 children with myopia in both eyes who met
specific inclusion and exclusion criteria, was attained with the
enrollment of 469 children in one year. Children were identified from
school screenings, clinic records, and referrals from local
practitioners. Eligible children were randomly assigned to receive
progressive addition or single vision lenses. Participating children
are being examined at 6-month intervals following baseline, for at
least 3 years, to measure changes in refractive error and to update
prescriptions, according to a specified protocol. A dilated examination
to evaluate the study outcome measures is performed at the annual study
visits. A standardized, common protocol is used at all centers.

The primary outcome of the study is progression of myopia, defined as
the magnitude of the change relative to baseline in spherical
equivalent refraction, determined by cycloplegic autorefraction. The
secondary outcome of the study is axial length measured by A-scan
ultrasonography.

Patient Eligibility
Children between the ages of 6 and 12 years with myopia in both eyes
(defined as spherical equivalent between -1.25 D and -4.50 D in each
eye as measured by cycloplegic autorefraction), astigmatism less than
or equal to 1.50 D, and no anisometropia (defined as a difference in
spherical equivalent between the two eyes greater than 1.0 D) were
eligible for inclusion. Exclusion criteria included visual acuity
greater than 20/25, strabismus, use of contact lenses, birth weight
less than 1,250 grams, use of bifocal or progressive addition lenses,
or any conditions precluding adherence to the protocol.

Patient Recruitment Status
Completed. Child recruitment began in September 1997 and was completed
in September 1998.

Current Status of Study
Ongoing

Results
The mean age of the 469 COMET children at baseline is 9.3 years (range
6-11 years); 52 percent are female. This group of children is
ethnically diverse, according to a self-report, with 46 percent white,
26 percent African-American, 14 percent Hispanic, and 8 percent Asian.
Mean residual accommodation measured twenty minutes after instillation
of two drops of tropicamide (1 percent) was found to be small (0.38D in
the right eye and 0.30D in the left eye). Thus, tropicamide (1 percent)
is an effective cycloplegic agent in myopic children. Baseline mean (±
sd) cycloplegic refractive correction in COMET children is -2.38 D (±
0.81) in the right eye and -2.40 D (± 0.82) in the left eye. Young
children have significantly less myopia than older children, but the
amount of myopia does not differ by gender or ethnicity. Mean axial
dimensions are: 4.0 ± 0.2 mm (anterior chamber), 3.4 ± 0.2 mm (lens),
16.8 ± 0.7 mm (vitreous chamber), and 24.1 ± 0.7 mm (axial length).
Girls have significantly shorter eyes than boys. Mean corneal radii are
7.73 mm (horizontal) and 7.59 mm (vertical). Ninety-five percent of the
children have a ratio of axial length to corneal radius greater than
3.0. These baseline measures provide cross-sectional data on a large
group of ethnically diverse myopic children and will serve as a basis
for examining changes that occur over a minimum of three years of
follow-up.

Use of PALs compared with SVLs slowed the progression of myopia in
COMET children by a small, statistically significant amount only during
the first year. The size of the treatment effect remained similar and
significant for the next 2 years. The results provide some support for
the COMET rationale-that is, a role for defocus in progression of
myopia.

The small magnitude of the effect does not warrant a change in clinical
practice.

Publications
Gwiazda J, Marsh-Tootle W, Hyman L, Norton T, and the COMET group:
Baseline refractive and ocular component measures of children enrolled
in the Correction of Myopia Evaluation Trial (COMET). Invest Ophthalmol
Vis Sci, in press.

Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC,
Manny R, Marsh-Tootle W, Scheiman M, and the COMET Group: A randomized
clinical trial of progressive addition lenses versus single vision
lenses on the progression of myopia in children. Invest Ophthalmol Vis
Sci 44: 1492-1500, 2003.

Hyman L, Gwiazda J, Marsh-Tootle W, Norton T, and the COMET Group: The
Correction of Myopia Evaluation Trial (COMET): Design and baseline
characteristics. Controlled Clinical Trials 22: 573-592, 2001.

Manny R, Hussein M, Scheiman M, Kurtz D, Nieman K, Zinzer K, and the
COMET Study Group: Tropicamide (1%): An effective cycloplegic agent for
myopic children. Invest Ophthalmol Vis Sci 42: 1728-1735, 2001.

Clinical Centers

Alabama
Wendy Marsh-Tootle, O.D.
University of Alabama-Birmingham
School of Optometry
1716 University Boulevard
Birmingham, AL 35294-0010
Telephone: (205) 934-5702
Fax: (205) 934-6758

Massachusetts
Daniel Kurtz, O.D., Ph.D.
New England College of Optometry
424 Beacon Street
Boston, MA 02115
Telephone: (617) 236-6251
Fax: (617) 369-0168

Pennnsylvania
Mitchell Scheiman, O.D.
Pennsylvania College of Optometry
1200 West Godfrey Avenue
Philadelphia, PA 19141-3399
Telephone: (215) 276-6057
Fax: (215) 276-6108

Texas
Ruth Manny, O.D., Ph.D.
University of Houston, College of Optometry
4901 Calhoun
Houston, TX 77204-6052
Telephone: (713) 743-1944
Fax: (713) 743-2053

Resource Centers

Chairman's Office
Jane Gwiazda, Ph.D.
New England College of Optometry
424 Beacon Street
Boston, MA 02115
Telephone: (617) 236-6234
Fax: (617) 369-0188
E-mail: gwiazdaj@neoptometry.edu

Coordinating Center
Leslie Hyman, Ph.D.
M. Cristina Leske, M.D., M.P.H.
Division of Epidemiology
Department of Preventive Medicine
University Medical Center
Stony Brook, NY 11794-8036
Telephone: (516) 444-7525
E-mail: lhyman@prevmed.som.sunysb.edu

NEI Representative

Donald Everett, M.A.
National Eye Institute
National Institutes of Health
Executive Plaza South, Suite 350
6120 Executive Boulevard MSC 7164
Bethesda, MD 20892-7164
Telephone: (301) 496-5983
Fax: (301) 402-0528

Data and Safety Monitoring Committee

Ex Officio Members

M. Cristina Leske, M.D., M.P.H.
Division of Epidemiology
Department of Preventive Medicine
University Medical Center
Stony Brook, NY 11794-8036
Telephone: (516) 444-7525
Fax: (516) 444-7525

Robert J Hardy, Ph.D. (Chair)
University of Texas
Health Science Center at Houston
School of Public Health
Coordinating Center, Suite E827
1200 Herman Pressler
Houston, TX 77031
Telephone: (713) 500-9550
Fax: (713) 500-9530

Argye Hillis, Ph.D.
Director of Clinical Epidemiology and Biostatistics
Scott and White Memorial Hospital/Foundation
Texas A&M Health Science Center
2401 South 31st Street
Temple, TX 76706
Telephone: (817) 724-3307
Fax: (817) 662-3867

Don Mutti, O.D., Ph.D.
College of Optometry
Ohio State University
338 W. 10th Avenue
Columbus, OH 43210
Telephone: (614) 247-7057
Fax: (614) 247-7058

Richard Stone, M.D.
Department of Ophthalmology
University of Pennsylvania Medical School
D603 Richards Building
3700 Hamilton Walk
Philadelphia, PA 19104-6075
Telephone: (215) 898-6950
Fax: (215) 898-0528

Sr Carol Taylor, R.N., Ph.D.
Georgetown University
School of Nursing
3700 Reservoir Road, NW
Washington, DC 20007

Ex Officio Members

Donald Everett, M.A.
National Eye Institute
National Institutes of Health
Executive Plaza South, Suite 350
6120 Executive Boulevard
Bethesda, MD 20892
Telephone: (301) 496-5983
Fax: (301) 402-0528

Jane Gwiazda, Ph.D.
Department of Vision Science
Assistant Professor
New England College of Optometry
424 Beacon Street
Boston, MA 02115
Telephone: (617) 236-6234
Fax: (617) 424-9202

Mohamed Hussein, Ph.D.
Department of Preventive Medicine
University Medical Center at Stony Brook
Stony Brook, NY 11794-8036
Telephone: (516) 444-2140
Fax: (516) 444-7525

Leslie Hyman, Ph.D.
Division of Epidemiology
Department of Preventive Medicine
University Medical Center
Stony Brook, NY 11794-8036
Telephone: (516) 444-7525
Fax: (516) 444-7525

Last Updated: 3/25/2003

This page was last modified in November 2004
otisbrown@pa.net - 21 Feb 2005 05:18 GMT
Dear MT,

Given the "blasts" the RM posts,
(and you repeat), followed by
Jan's statement that the concept
of the plus-preventive "second opinion"
MUST BE DESTROYED, and I would
suggest you are a hypocrite.

Fruther -- I do not advocate that a
BI-FOCAL be used.  If you
are gong to do something -- do it
right.  That means, while the
person still PASSES the
DMV, he makes a decision
to BEGIN using the plus.
He has nothing to lose.

But that type of decision, would
turn responsibility can CONTROL
over to him -- and that
is not MEDICAL in concept
or execution.

You asked for INDICATIONS of
the result of a PREVENTIVE study.

The Oakley-Young intimates
the result of a well-ruen ENGINEERING
(NOT MEDICAL) study run for
prevention -- with engineers
IN CONTROL.

It would make all the difference -- where
the person knows the "score"
and will "intellectually" participate
and actually use the plus "correctly".

This would REQUIRE that detailed
instructions be provided, and that
would absolutly PREVENT a
"blind" study.

An engineering-scientific study
had no "blind" requirement.

Best,

Otis
Engineer
Jan - 21 Feb 2005 11:14 GMT
> Dear MT,
>
[quoted text clipped - 4 lines]
> MUST BE DESTROYED, and I would
> suggest you are a hypocrite.

And this is what I (Jan) realy said and keep saying until you deliver proof
that forces me to draw back my conclusion.
Signature

Free to  Marcus Porcius Cato: ''Ceterum censeo Carthaginem esse delendam"

In conclusion, I think that the "Otis therapy" should be destroyed

Jan (normally Dutch spoken)

Snip.......

> You asked for INDICATIONS of
> the result of a PREVENTIVE study.
[quoted text clipped - 17 lines]
> An engineering-scientific study
> had no "blind" requirement.

Okay Otis, than show us  results wich can be verified instead of anectodes
of your famous pilots, nephews, nieces, grandchilds etc... for a start.
O, and do not forget to cc this posting to uncle Arnie and aunt Edith.

Signature

Free to  Marcus Porcius Cato: ''Ceterum censeo Carthaginem esse delendam"

In conclusion, I think that the "Otis therapy" should be destroyed

Jan (normally Dutch spoken)

A Lieberman - 21 Feb 2005 13:14 GMT
> The Oakley-Young intimates
> the result of a well-ruen ENGINEERING
> (NOT MEDICAL) study run for
> prevention -- with engineers
> IN CONTROL.

Otis,

I asked this in another post and I will ask again!!!

Please "entertain" me!!!!  

Where on the web OUTSIDE your website is this Oakley - Young study on the
web????  NOT ON YOUR WEBSITE, but a website that is unbiased.

Or is this another imaginary thing like your subjects....

Allen
Mike Tyner - 21 Feb 2005 14:22 GMT
> The Oakley-Young intimates
> the result of a well-ruen ENGINEERING
> (NOT MEDICAL) study run for
> prevention -- with engineers
> IN CONTROL.

Show us your technique works for humans, and we'll use it. I promise.

-MT
A Lieberman - 20 Feb 2005 00:24 GMT

> The Oakley-Young study demonstrated that a "high plus"
> where the child actually looked THROUGH THE PLUS

Otis,

Please "entertain" me!!!!  

Where on the web OUTSIDE your website is this Oakley - Young study on the
web????  NOT ON YOUR WEBSITE, but a website that is unbiased.

Allen
RM - 20 Feb 2005 01:51 GMT
Dear Prevention minded friends,

I am a practicing optometrist.  Today I had an adolescent male patient who I
had seen previously 3 years ago.  At that time his refraction was
approximately -3.00-1.00 X 180 in both eyes.  He bought a pair of glasses
and wore them for about 6 months but then  lost them.  He has been going
around for the last 2.5 years without any spectacle correction at all.  This
condition is optically equivalent to wearing  +3.00-1.00 x 180 lenses in
both eyes all the time.  His refraction again today was the same as what it
was 3 years ago.  If Otis' theory of plus lens prevention is correct, then
why didn't this patient's refraction improve?

I have asked this question of Otis many times before and he never answers.
Otis-- please answer this time.  Why not ask your good friends Dr. Young,
Dr. Cheung, etc. to reply since you obviously are at a loss.

PS-- for anyone really interested in the REAL TRUTH about the status of
scientific research regarding myopia prevention, I offer the following
unbiased medical references:

1. http://annals.edu.sg/pdf200401/V33N1p4.pdf
2.
http://www.revoptom.com/index.asp?ArticleType=SiteSpec&page=osc/apr01/lesson_0401.htm
3. http://dels.nas.edu/ilar/jour_online/40_2/V40_2NortonAnimalModels.asp
4. http://www.optometrists.asn.au/gui/files/ceo865276.pdf

Regards,

RM PhD OD
Jan - 20 Feb 2005 12:35 GMT
> Dear Prevention minded friends,
>
[quoted text clipped - 5 lines]
> This condition is optically equivalent to wearing  +3.00-1.00 x 180 lenses
> in both eyes all the time.

Mistype RM?

Refraction error S+3,00=C+1,00 180?

> Regards,
>
> RM PhD OD

Signature

Free to  Marcus Porcius Cato: ''Ceterum censeo Carthaginem esse delendam"

In conclusion, I think that the "Otis therapy" should be destroyed

Jan (normally Dutch spoken)

RM - 20 Feb 2005 16:40 GMT
Sorry  ;)

---------

> Mistype RM?
>
> Refraction error S+3,00=C+1,00 180?
RM - 20 Feb 2005 18:55 GMT
> Dear Friends,
>
> Since RM posts "blasts" against vision scientists
> like Dr. Francis Young

Quit trying to misquote and misrepresent me Otis.  I post warnings (you like
to call them "blasts") only against YOU --  not others.  YOU have no
training or understanding of the functioning of the human eye.  You are just
a single-minded zealot.  You never listen to reason or scientific facts.

Dr. Young was one of a group of optometrists who believed some time ago that
myopia progression might be arrested or reduced by using plus lenses.  Since
those early days a number of human studies have shown NO EFFICACY for that
form of treatment.  Only die-hard zealots like yourself continue to argue
the point.

Do not misquote and lie any more Otis.  I have kept a long listing of the
examples of your lying and I will be happy to post it to everyone.

For those that are truly interested in the topic of myopia prevention, I am
happy to provide the following current medical references for your personal
evaluation.

http://annals.edu.sg/pdf200401/V33N1p4.pdf
http://www.revoptom.com/index.asp?ArticleType=SiteSpec&page=osc/apr01/lesson_0401.htm
http://dels.nas.edu/ilar/jour_online/40_2/V40_2NortonAnimalModels.asp
http://www.optometrists.asn.au/gui/files/ceo865276.pdf
otisbrown@pa.net - 21 Feb 2005 05:03 GMT
Dear RM,

Professor Theodore Grosvenor -- YES PH.D. Optometrist
stated that it would be WISE to begin the
use of a PLUS PREVENTIVE lens BEFORE
the nearsighedness even starts.

This is EXACTLY MY POSITION -- no more -- no less

Francis Young is a vision scientists -- world famous
He stated the same concept concerning the
dynamic behavior of the natural eye.
Dr. Grosvenor -- said exactly the same thing,

Prevention is indeed difficult -- and depends on
the person (not you and your "blasts" against
these other people.

The plus is indeed the "second opinion" but
the person should be informed of this
choice BEFORE ANY LENS IS USED.

The choice shouild belong to the individual
since even starting with the minus lens
will have life-time consequences.

It is not up to me to make that choice.

You "blasts" are in fact against
the second opinion -- so you can
spin the dials on your phoropter
and not take any responsibility
for the consequences.

Fortunately, some ODs are recognizing this
basic professional responsibility -- even
if you do not.

So, but "unknown" freind (are you Robin Parsons, morphed
into "RM") post another "blast" to keep you position.

You can fool all the people some of the time.

You can fool some of the people all the time.

But eventually you can not fool all the people all the time.

Best,

Otis
Engineer

[RM's "Blast" will be posted below for those people
who wish to be denied access to the
"second opinion" at the threshold -- when
it must be used to be effective. ]

Neither "medicine" nor science is ever
"set in stone" and I would keep this in
mind as we review the proven behavior
of the dynamic eye.
RM - 21 Feb 2005 14:51 GMT
>(not you and your "blasts" against
> these other people.

Please post a link to the "blasts" that I have made against other people.

I only make them against YOU Otis because you give unlicensed medical advice
to people, which is illegal, and you should be stopped!

> The plus is indeed the "second opinion" but
> the person should be informed of this
> choice BEFORE ANY LENS IS USED.

Oh.  So if the dynamic natural eye uses a minus lens only for a short time,
it is irrevocably changed.  It changes from dynamic to static?  Is that what
you are saying?  That wretched minus!

> You "blasts" are in fact against
> the second opinion

So now you are trying to redefine my remarks again!  Read my lips -- my
warnings (you like to call them "blasts") are only against YOU.  Because you
are an unlearned fool who by your own admission doesn't understand anything
about the anatomy and physiology of the human eye.

Readers beware.  Avoid Otis the Engineer!

> [RM's "Blast" will be posted below for those people
> who wish to be denied access to the
> "second opinion" at the threshold -- when
> it must be used to be effective. ]

Yes.  You figured it out.  My goal is to deny people access to plus lenses.
Soon our legions will disperse to all the drug stores around the world and
collect all the plus reading glasses and burn them!

Our next conspiracy meeting in Jamaica in March will discuss this plan along
with our other strategies to take over the world and force everyone to wear
eyeglasses for eternity!

> Neither "medicine" nor science is ever
> "set in stone" and I would keep this in
> mind as we review the proven behavior
> of the dynamic eye.

All we have ever asked you is to show us the proof that you keep speaking of
Otis.

Go take another thorazine!
Mike Tyner - 23 Feb 2005 02:24 GMT
> http://www.optometrists.asn.au/gui/files/ceo865276.pdf

Actually, the last paragraph of this paper is very supportive of plus lens
treatment.

No proof, but a little biochemistry to justify somebody's next project.

-MT
RM - 23 Feb 2005 12:40 GMT
I noticed that.  The other references also discuss plus lenses and bifocal
therapy in a neutral light.  I said these papers were objective and unbiased
as they should be.

I think there IS value for some patients with plus lens therapy.   The
question is which ones.  A problem is someone needs to prove it and define
it a little better.  A large in-depth longitudinal study using A-scans, Orb
scans, careful consistent refractions etc. of different age groups might
show a benefit for a subpopulation of patients.   You would have to wonder
whether, since muscarinic antagonists, and bifocal corrections, seem to
sporadically show some positive influence, accommodation being controlled
via plus lenses might not work for some people too.

I can see Otis' next post-- "Even the unknown RM (aka Robin Parsons) who
slams the "second opinion" admits that he recommends +3 glasses to all his
patients".

Otis-- when you read this be sure you get the message.  Your "model" is weak
and insufficient.  You need to prove what subgroup of patients might benefit
from plus lens (if any at all).  Prove it, and no one will argue with you.
Go around giving unfounded advice is practicing medicine without a license
and you will be continuously opposed.

PS:  Hint-- the eye is most "dynamic" in young people (ages 0-18).  Your
chance of showing that plus lenses influence the anatomy of the eye most
likely lies within that group.  Once the anatomy is set, then the only group
where plus lenses will help will be accommodative myopes.
======================

>> http://www.optometrists.asn.au/gui/files/ceo865276.pdf
>
[quoted text clipped - 4 lines]
>
> -MT
yanding@speakeasy.net - 23 Feb 2005 18:58 GMT
I have read the report, and clearly the study indicates the most
efficient time period for myopia prevention is before the human stop
growing, such as before 12-15 years age.  According to the study, human
constantly adjust the growth of the eye based on the stimuli: "stop" or
"growth", which are based on the kind of blur the eye received.  By
this theory, letting a myopic child wear a plus lens before the child
finish growing should help generating the "stop" signal the eye needed
to stop the eyeball from further elongation.  Furthermore, the study
suggests, even after the eyeball has already elongated, if the child
has not finished his/her growth, there is still chance for the eyeball
to become round again since the overall eyeball size will be larger.
Anyway, that is my understanding about the study, and in my opinion a
very good one.  Otis has always suggested to use plus lens on myopic
children when onset, so he is right along with this study.  Anyway, I
do not have the intention to debate on this issue.  Sometimes people
get lost when they just want to prove they were right at first place.

Yan

> I noticed that.  The other references also discuss plus lenses and bifocal
> therapy in a neutral light.  I said these papers were objective and unbiased
[quoted text clipped - 33 lines]
> >
> > -MT
RM - 24 Feb 2005 00:21 GMT
The paper is a review paper.  The section where this is discussed is in the
"discussion" part of the paper.  You understand correctly what the author
speculates about.  Unfortunately none of it is proven.  It is only theory at
this point.  While it seems logical, scientific studies need to be
performed.  And I speculate that this approach would not work for all
adolescents.  I believe studies using plus lenses have been tried before
without success.

Otis proposes much more that treating 12-15 year olds with plus lenses.

-------

>I have read the report, and clearly the study indicates the most
> efficient time period for myopia prevention is before the human stop
[quoted text clipped - 72 lines]
>> >
>> > -MT
otisbrown@pa.net - 24 Feb 2005 16:56 GMT
Dear RM,

Subject:  What I advocate.

What I propose is that a pilot who is entering a four year
college be presented with the engineering concept that
the natural eye is dynamic.  This person would
be only on the THRESHOLD, i.e., could still pass
the DMV test but was SLIGHTLY nearsighed.
(A negative refractive state of the natural eye -- in
my parlance.)

This is a very LIMITED proposal, since no action
could be taken until the pilot was convinced
as to the necessity of his taking complete
control and doing all the confirming measurements
himself.

That means he would measure his refractive
state using a phoropter (with a two-man team)
and he would confirm all measurements
as an engineering (not medical) study.

I believe in this type of limited effort a
high percentage of motivated pilots
would clear both their 20/40 eyes
to 20/20, and confirm that the
refractive status of their natural eyes
would change from a negative value
to a positive value -- as THEY  measure it.

This would be in the face of the know fact
that the refractive status of college students
goes "down" by between -1.1 diopters to
-1.6 diopters at West Point.

If these pilots were successfull -- i.e., cleared
to 20/20, with refractive status moving "positive"
then they will have proved what we alrady
know about the beahvior of the natural eye.

The only issue is the practical implementation of
this effort on as scientific (not medical) level.

Best,

Otis
Engineer
RM - 25 Feb 2005 02:12 GMT
You are right, this is extremely LIMITED.

Why do you think the most-likely-to-respond segment of the population with
regard to plus lens therapy would be "pilot-engineers entering a 4-year
college".  That scientifically makes no sense.  The eye is most "dynamic" in
the actively growing child when axial length, corneal curvature, lens
curvature, etc. can be most likely influenced.  Your "theory" would be most
likely to be proven correct if you could do a longitudinal study comparing
no-treatment, minus lens treatment, and plus lens treatment therapies.  You
would need a small group of professionally trained (and consistently
trained) refractionists to periodically measure refractive error as well as
several other interesting parameters (axial length, corneal topography,
etc.) in numerous subjects.  The treatment groups would need to be "blinded"
to the researchers as much as possible (perhaps the subjects wouldn't bring
in their glasses on the days they got their exams so the refractionist
wouldn't be able to tell if they were plus, minus, or whatever).  This would
have to be a longitudinal study lasting for 10-15 years.  If you do anything
short of something like this, like have "two-man teams" or do an
"engineering (not medical) study" you will make no headway convincing
anybody of anything.

All medical, and scientific studies must be unbiased and controlled Otis,
otherwise they are not valid!  You will continue to have no credibility with
anyone.

=====================

> Dear RM,
>
[quoted text clipped - 44 lines]
> Otis
> Engineer
otisbrown@pa.net - 24 Feb 2005 16:45 GMT
Dear Yan,
You are correct when you preceive tha the natural eye
is "dynamic" and that is true-prevention is to be
achieved, that process must START before a
minus lens is applied.  This concept, while difficult,
is in fact the second-opinion.  Further it is reflected
in the fact that some ODs are getting their own
children to wear the plus, when the child still
has 20/20, but a refractive status of zero.

Further, the recognition, by professor Theodore Grosvenor
U. o f Houston was that this is an either-or decision
the parents and child must make -- BEFORE the minus lens
is applied.

If you child is on the THRESHOLD of nearsighedness,
i.e., passes the legal 20/40 line, but is slightly nearsighed,
then it would be good to be aware of this
advocacy for fundamental "change".  You have
nothing to lose.  You might enjoy reading
Steve Leung's opinion on the subject.

www.chinamyopia.org

There is no "right" or "wrong" here -- only your
right to an "informed" choice.

Keep an open mind.  Understanding new ideas and
concepts can not hurt you.

Enjoy,

Otis
Engineer
otisbrown@pa.net - 24 Feb 2005 16:45 GMT
Dear Yan,
You are correct when you preceive tha the natural eye
is "dynamic" and that is true-prevention is to be
achieved, that process must START before a
minus lens is applied.  This concept, while difficult,
is in fact the second-opinion.  Further it is reflected
in the fact that some ODs are getting their own
children to wear the plus, when the child still
has 20/20, but a refractive status of zero.

Further, the recognition, by professor Theodore Grosvenor
U. o f Houston was that this is an either-or decision
the parents and child must make -- BEFORE the minus lens
is applied.

If you child is on the THRESHOLD of nearsighedness,
i.e., passes the legal 20/40 line, but is slightly nearsighed,
then it would be good to be aware of this
advocacy for fundamental "change".  You have
nothing to lose.  You might enjoy reading
Steve Leung's opinion on the subject.

www.chinamyopia.org

There is no "right" or "wrong" here -- only your
right to an "informed" choice.

Keep an open mind.  Understanding new ideas and
concepts can not hurt you.

Enjoy,

Otis
Engineer

Rate this thread:






 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.